Pediatric Fungal Keratitis: Predisposing Factors, Clinical Features, and Outcomes During a 24-Year Study

儿童真菌性角膜炎:一项为期24年的研究揭示了其易感因素、临床特征和预后

阅读:3

Abstract

PURPOSE: To investigate the clinical features, antifungal susceptibility patterns, and treatment outcomes of pediatric fungal keratitis (FK) at a tertiary eye center in North China. METHODS: A retrospective study of pediatric FK cases diagnosed between July 2000 and October 2023 at Beijing Tongren Hospital, confirmed by fungal culture or microscopy. Data on demographics, predisposing factors, clinical signs, microbiological findings, treatment, and prognosis were analyzed. RESULTS: Eighty-eight pediatric FK cases (66 males, 22 females; mean age 10.8 ± 2.3 years) were collected. Trauma history (35.2%) was primarily from toys and writing tools. Dense infiltrates (100%), feathery margins (69.2%), and multifocal lesions (38.5%) were the common features. Hypopyon was less frequent (15.5%); no endothelial plaques, collar-button lesions, and pigment deposits were observed. Fusarium (43.9%) and Aspergillus (25.8%) were the predominant isolates. Amphotericin B demonstrated both in vitro and clinical efficacy. Treatment duration (median 48.1 days) varied by risk factors (P < 0.001), age (P = 0.013), and fungal type (P = 0.016). Multivariate analysis identified ocular surgery (hazard ratio [HR] = 0.04, P < 0.001) and toddler age (HR = 3.67, P = 0.013) as the strongest predictors of prolonged and faster treatment duration, respectively. CONCLUSIONS: Trauma is the leading risk factor of pediatric FK in North China, with Fusarium and Aspergillus being the predominant pathogens. Amphotericin B is the most effective antifungal, and early diagnosis and treatment are critical for improving outcomes. TRANSLATIONAL RELEVANCE: This study provides evidence-based data on fungal trends, antifungal susceptibility, and treatment outcomes, guiding optimal drug selection and therapeutic strategies to reduce visual impairment in pediatric FK.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。